Federal (United States) · Session law
Subtitle A
11 sections
11 sections
- Pub. L. 115-271, tit. III, subtit. A, ch. 1, sec. 3001CLARIFYING FDA REGULATION OF NON-ADDICTIVE PAIN PRODUCTS.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 1, sec. 3002EVIDENCE-BASED OPIOID ANALGESIC PRESCRIBING GUIDELINES AND REPORT.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 2, sec. 3011SHORT TITLE.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 2, sec. 3012NOTIFICATION, NONDISTRIBUTION, AND RECALL OF CONTROLLED SUBSTANCES.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 2, sec. 3013SINGLE SOURCE PATTERN OF IMPORTED ILLEGAL DRUGS.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 2, sec. 3014STRENGTHENING FDA AND CBP COORDINATION AND CAPACITY.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 3, sec. 3021SHORT TITLE.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 3, sec. 3022RESTRICTING ENTRANCE OF ILLICIT DRUGS.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 4, sec. 3031SHORT TITLE.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 4, sec. 3032SAFETY-ENHANCING PACKAGING AND DISPOSAL FEATURES.Enacted
- Pub. L. 115-271, tit. III, subtit. A, ch. 5, sec. 3041CLARIFYING FDA POSTMARKET AUTHORITIES.Enacted